Male gonadal function in survivors of childhood Hodgkin and non-Hodgkin lymphoma

Pediatric Hematology and Oncology

Volumn 17, Issue 3, 2000, Pages 239-245

  Arush, Myriam Weyl Ben ^a,b   Solt, Ido ^a   Lightman, Abraham ^a   Linn, Shai ^a   Kuten, Avraham ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Cancer late effects; Fertility; Hodgkin; Lymphoma; Pediatrics

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; FOLLITROPIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ARTICLE; AZOOSPERMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; ENDOCRINE SYSTEM; FERTILITY; GONAD FUNCTION; HODGKIN DISEASE; HUMAN; MALE; NONHODGKIN LYMPHOMA; OLIGOSPERMIA; PRESCHOOL CHILD; SCHOOL CHILD; SEMEN ANALYSIS;

EID: 0034082698     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800100276415     Document Type: Article

References (24)

1. Jenkins RDT, Berry MP. Hodgkin's disease in children. Semin Oncol. 1980;7:202-224.
2. Donaldson SS, Glatstein ER, Rosenberg SA. Pediatric Hodgkin's disease: results of therapy. Cancer. 1976;37:2436-2447.
3. Bonadonna G. Chemotherapy strategies to improve the control of Hodgkin's disease. Cancer Res. 1982;42:4309-4320.
4. Viviani S, Santoro A, Ragni G, Baonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin's disease: comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol. 1985;21:601-605.
5. Naccache P, Decaudin D, Koscielny S, Bendahmane B, Auger J, Munck JN. Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma: experience at the Gustave-Roussy Institute from 1980 to 1993. Bull Cancer Paris. 1996;83:307-314.
6. Bokemeyer C, Schmoll HJ, van-Rhee J, Kuczyk M, Schuppert F, Poliwoda H. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma. Ann Hematol. 1994;68:105-110.
7. Chapman RM, Sutcliffe SB, Malpas JS. Male gonadal dysfunction in Hodgkin's disease. JAMA. 1981; 245:1323-1328.
8. Marmor D, Elfant E, Dauchez C, Roux C. Semen analysis in Hodgkin's disease before the onset of treatment. Cancer. 1986;57:1986-1987.
9. Redman JR, Bajorunas DR, Goldstein MC, et al. Semen cryopreservation and artificial insemination for Hodgkin's disease. J Clin Oncol. 1987;5:233-238.
10. Viviani S, Ragni G, Santoro A, et al. Testicular dysfunction in Hodgkin's disease before and after treatment. Eur J Cancer. 1991;27:1389-1392.
11. Pennisi AJ, Grushkin CM, Lieberman E. Gonadal function in children with nephrosis treated with cyclophosphamide. Am J Dis Child. 1975;129:315-318.
12. Rosenthal J, Weyl Ben Arush M, Kuten A, Ben-Arieh J, Ben-Shahar M, Robinson E. Hodgkin's disease in childhood: treatment modalities, outcome and epidemiological aspects. Am J Pediatr Hematol Oncol. 1994;16:138-142.
13. Tanner JM. In: Growth at Adolescence, 2d ed. Oxford, UK: Blackwell Scientific; 1962.
14. Kreuser ED, Ziros N, Hetzel WD, Heimpel H. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease. J Cancer Res Clin Oncol. 1987;113: 260-266.
15. Sherins RG, Olweny CLM, Ziegler JL. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. N Engl J Med. 1978;299:12-16.
16. Green DM, Brecher ML, Lindsay AN, et al. Gonadal function in pediatric patients following treatment for Hodgkin's disease. Med Pediatr Oncol. 1981;9:235-244.
17. Aubier F, Flamant F, Brauner R, Caillaud JM, Chaussain JM, Lemerle J. Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol. 1989;7:304-309.
18. Dhabar BN, Malhotra H, Joseph R, et al. Gonadal function in prepubertal boys following treatment for Hodgkin's disease. Am J Pediatr Hematol Oncol. 1993;15:306-310.
19. Ortin T, Shostak CA, Donaldson S. Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys. 1990;194:873-880.
20. Clark ST, Radford JA, Crowther D, Swindell R, Shalet SM. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven drug hybrid regimen. J Clin Oncol. 1995;13:134-139.
21. Bramswig JH, Heimes U, Heiermann E, Schlegel W, Nieschlag E, Schellong G. The effects of different cumulative doses of chemotherapy on testicular function. Cancer. 1990;65:1298-1302.
22. Pryzant RM, Meistrich ML, Wilson G, Brown B, McLaughlin P. Long-term reduction in sperm count after chemotherapy with and without radiation therapy for non-Hodgkin's lymphomas. J Clin Oncol. 1993;11:239-247.
23. Lu CC, Meistrich ML. Cytotoxic effects of chemotherapeutic drugs on mouse testis cells. Cancer Res. 1979;39:3575-3582.
24. Bonadonna G, Santoro A, Viviani S, Lombardi G, Ragni G. Gonadal damage in Hodgkin's disease for cancer chemotherapeutic regimens. Arch Toxicol Suppl. 1984;1:140-145.